These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30660666)

  • 1. Desmoglein 1 Deficiency Causes Lethal Skin Blistering.
    Kugelmann D; Radeva MY; Spindler V; Waschke J
    J Invest Dermatol; 2019 Jul; 139(7):1596-1599.e2. PubMed ID: 30660666
    [No Abstract]   [Full Text] [Related]  

  • 2. Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3.
    Spindler V; Drenckhahn D; Zillikens D; Waschke J
    Am J Pathol; 2007 Sep; 171(3):906-16. PubMed ID: 17640963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemphigus: a complex T cell-dependent autoimmune disorder leading to acantholysis.
    Veldman C; Feliciani C
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):313-20. PubMed ID: 18097775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies.
    Cozzani E; Christana K; Mastrogiacomo A; Rampini P; Drosera M; Casu M; Murialdo G; Parodi A
    Eur J Dermatol; 2007; 17(6):530-3. PubMed ID: 17951135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemphigus, a pathomechanism of acantholysis.
    Furue M; Kadono T
    Australas J Dermatol; 2017 Aug; 58(3):171-173. PubMed ID: 28211055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris.
    Schlögl E; Radeva MY; Vielmuth F; Schinner C; Waschke J; Spindler V
    Front Immunol; 2018; 9():858. PubMed ID: 29922278
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro pathogenicity assay for anti-desmoglein autoantibodies in pemphigus.
    Ishii K; Amagai M
    Methods Mol Biol; 2013; 961():219-25. PubMed ID: 23325646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemphigus Herpetiformis With Autoantibodies to Desmoglein 1 and 3.
    Galvañ-Pérez Del Pulgar JI; Tercedor-Sánchez J; Jiménez-Gallo D; Linares-Barrios M
    Actas Dermosifiliogr; 2016 Nov; 107(9):785-786. PubMed ID: 27340117
    [No Abstract]   [Full Text] [Related]  

  • 10. Smaller desmosomes are seen in the skin of pemphigus patients with anti-desmoglein 1 antibodies but not in patients with anti-desmoglein 3 antibodies.
    van der Wier G; Pas HH; Kramer D; Diercks GFH; Jonkman MF
    J Invest Dermatol; 2014 Aug; 134(8):2287-2290. PubMed ID: 24621791
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous type of pemphigus vulgaris.
    Gheisari M; Shahidi-Dadras M; Nasiri S; Dargah SM; Dadkhahfar S; Abdollahimajd F
    J Am Acad Dermatol; 2020 Sep; 83(3):919-920. PubMed ID: 31931088
    [No Abstract]   [Full Text] [Related]  

  • 12. Frequency of shifts over time in the profile of antidesmoglein antibodies in pemphigus vulgaris.
    Weitz D; Bystryn JC
    Arch Dermatol; 2007 Aug; 143(8):1073-4. PubMed ID: 17709673
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns.
    Parlowsky T; Welzel J; Amagai M; Zillikens D; Wygold T
    J Am Acad Dermatol; 2003 Apr; 48(4):623-5. PubMed ID: 12664033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic rescue of desmoglein 3 null mice with desmoglein 1 to develop a syngeneic mouse model for pemphigus vulgaris.
    Hata T; Nishifuji K; Shimoda K; Sasaki T; Yamada T; Nishikawa T; Koyasu S; Amagai M
    J Dermatol Sci; 2011 Jul; 63(1):33-9. PubMed ID: 21602032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction.
    Heupel WM; Zillikens D; Drenckhahn D; Waschke J
    J Immunol; 2008 Aug; 181(3):1825-34. PubMed ID: 18641320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship.
    Sayar BS; Rüegg S; Schmidt E; Sibilia M; Siffert M; Suter MM; Galichet A; Müller EJ
    Exp Dermatol; 2014 Jan; 23(1):33-8. PubMed ID: 24279293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of pemphigus herpetiformis with absence of antibodies to desmogleins 1 and 3.
    Miura T; Kawakami Y; Oyama N; Ohtsuka M; Suzuki Y; Ohyama B; Hashimoto T; Motoki Y; Yamamoto T
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):101-3. PubMed ID: 20050294
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid transition from pemphigus vulgaris to pemphigus foliaceus.
    Ito T; Moriuchi R; Kikuchi K; Shimizu S
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):455-7. PubMed ID: 25376758
    [No Abstract]   [Full Text] [Related]  

  • 19. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
    Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the "true" pathogenic anti-desmoglein antibodies?
    Muro Y; Sugiura K; Akiyama M
    Acta Derm Venereol; 2015 Sep; 95(7):872, 874. PubMed ID: 25881972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.